Korean memory giants await super bumper years on AI harvest SEOUL, September 23 (AJP) - South Korea’s memory giants and investors are betting on a looming chip super cycle that could prove the most lucrative and enduring yet, fueled by the surging appetite for artificial intelligence (AI). SK hynix is poised to lead the AI-driven memory race, having leapt ahead in conventional DRAM and seized the initiative in high-bandwidth memory (HBM), a critical component for powering AI chips. The company is expected to command at least half of September 23, 2025

Hyundai Capital launches financing services for car buyers in Indonesia SEOUL, September 23 (AJP) - South Korean financing company Hyundai Capital said Tuesday it had launched a new automotive finance company in Indonesia, aiming to strengthen its foothold in one of Southeast Asia’s fastest-growing car markets. The joint venture, created with Indonesia’s Sinarmas conglomerate and Shinhan Bank Indonesia, will operate under the brand name Hyundai Finance. The company plans to offer a suite of services for car buyers, including deferred September 23, 2025

LIG Nex1 signs pact with Airbus to bolster air defense cooperation SEOUL, September 23 (AJP) - South Korean defense firm LIG Nex1 said Tuesday it had signed an agreement with Airbus Defense and Space to expand collaboration on integrated air defense systems. The agreement, finalized on Sept. 22 at LIG Nex1’s headquarters in Pangyo, Gyeonggi Province, builds on an earlier pact signed during the Seoul International Aerospace and Defense Exhibition in 2023. Company officials said the latest deal aims to strengthen research in integrated a September 23, 2025

Celltrion shares jump on deal to acquire Eli Lilly and fend off US tariff risks SEOUL, September 23 (AJP) - South Korean biopharmaceutical company Celltrion's shares surged upon a major M&A deal in the United States, setting the contract-based drug maker better positioned against U.S. tariff exposure. The company said on Tuesday its U.S. operation signed a deal to acquire Eli Lilly's biopharmaceutical manufacturing facility in Branchburg, New Jersey for about 460 billion won ($330 million), with an aim to close the deal by the end of the year. Sh September 23, 2025